Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07472257
Eligibility Criteria:
Inclusion criteria:
* Diagnosis of chronic tinnitus, defined as a tinnitus duration of at least 6 months
* Written informed consent: The patient must be able to understand the study information, comply with the required examinations and appointments, and provide written informed consent
* Male or female patients, aged 18-75 years
Exclusion criteria:
* Objective tinnitus
* Tinnitus below 1000 Hz
* Presence of Menière's disease, otosclerosis, acoustic neuroma, or other clearly identifiable and treatable causes of tinnitus
* Initiation of other tinnitus treatments within the last three months prior to study entry
* Lack of informed consent
* Oropharyngeal infection
* Presence of clinically relevant severe internal, neurological, or psychiatric disorders
* Drug, medication, or alcohol abuse within 12 weeks prior to study entry
* Any other condition that, in the opinion of the investigator, makes participation in the study unsuitable
* Hyperacusis
* Current pharmacological treatment with psychoactive substances (e.g., antidepressants, anticonvulsants)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT07472257
Study Brief:
Protocol Section:
NCT07472257